The chemoadjuvant potential of grape seed procyanidins on p53-related cell death in oral cancer cells

J Oral Pathol Med (2012) 41: 322–331 Background:  To clarify the efficacy of grape seed procyanidin (GSP) on antiproliferative effects related to p53 functional status of oral squamous cell carcinoma (OSCC) for its chemoadjuvant potential. Methods:  We used GSP to investigate SCC‐25 cells with wild‐...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of oral pathology & medicine 2012-04, Vol.41 (4), p.322-331
Hauptverfasser: Lin, Yaoh-Shiang, Chen, Su-Feng, Liu, Chia-Lin, Nieh, Shin
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 331
container_issue 4
container_start_page 322
container_title Journal of oral pathology & medicine
container_volume 41
creator Lin, Yaoh-Shiang
Chen, Su-Feng
Liu, Chia-Lin
Nieh, Shin
description J Oral Pathol Med (2012) 41: 322–331 Background:  To clarify the efficacy of grape seed procyanidin (GSP) on antiproliferative effects related to p53 functional status of oral squamous cell carcinoma (OSCC) for its chemoadjuvant potential. Methods:  We used GSP to investigate SCC‐25 cells with wild‐type p53 gene and OEC‐M1 cells with mutant p53 gene for the assessment of antiproliferative effects including cell viability, cell cycle, apoptosis, migration and invasion potential, and alterations of associated oncoproteins involved in cellular and molecular events. Results:  The findings suggest that GSP on OEC‐M1 cells leads to cell cycle arrest by increasing the expression of p21Cip1/p27Kip1 protein without functioning mitochondria‐mediated apoptosis, whereas GSP on SCC‐25 cells inhibits cell proliferation via both G1‐phase arrest and mitochondria‐mediated apoptosis in a dose‐dependent manner as a result of alterations of Bcl‐2. GSP also inhibits the migration and invasion of both cells, which are associated with the suppression of matrix metalloproteinases (MMPs), MMP‐2 and MMP‐9. Conclusion:  Antiproliferative effectiveness of GSP is closely associated with the p53 status of OSCC cells. GSP displays chemoadjuvant potential via cell cycle blockage and apoptotic induction. Our findings clearly suggest that GSP may play a role as a novel chemopreventive or therapeutic agent for OSCC.
doi_str_mv 10.1111/j.1600-0714.2011.01103.x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_929507492</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1022564249</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4693-8fcc232f4469f7fc4a0485374ff91e7c84b5e8d6ed87f26df17718250e3caaac3</originalsourceid><addsrcrecordid>eNqNkV9v0zAUxS0EYt3GV0B-QfCS4P9OHnhAE4xNE4NRtEfLc66pS5pkdsrab4-zlvKGsGTZ1v0d-_hchDAlJc3j7bKkipCCaCpKRigt8yS83DxBs0PhKZqRmoiCScqO0HFKS0Ko5oI-R0eMZbxm9QzBfAHYLWDV22a5_mW7EQ_9CN0YbIt7j39EOwBOAA0eYu-2tgtN6BLuOzxIXkRo7ZhrDtoWN2DHBQ4d7mMWO9s5iI-VdIqeedsmeLFfT9D3jx_mZ5-Kq-vzi7P3V4UTquZF5Z1jnHmRT157JywRleRaeF9T0K4SdxKqRkFTac9U46nWtGKSAHfWWsdP0Ovdvdnr_RrSaFYhTQ5sB_06mfxlSbSoWSbf_JOkhDGpBBN1Rqsd6mKfUgRvhhhWNm4zZKZ2mKWZUjdT6mZqh3lsh9lk6cv9K-u7FTQH4Z_8M_BqD9jkbOtjDi2kv5xUqpKKZ-7djnsILWz_24C5vP4y7bK-2OlDGmFz0Nv40yjNtTS3n88NF2r-7Su5Mbf8N1iwtDo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1022564249</pqid></control><display><type>article</type><title>The chemoadjuvant potential of grape seed procyanidins on p53-related cell death in oral cancer cells</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Lin, Yaoh-Shiang ; Chen, Su-Feng ; Liu, Chia-Lin ; Nieh, Shin</creator><creatorcontrib>Lin, Yaoh-Shiang ; Chen, Su-Feng ; Liu, Chia-Lin ; Nieh, Shin</creatorcontrib><description>J Oral Pathol Med (2012) 41: 322–331 Background:  To clarify the efficacy of grape seed procyanidin (GSP) on antiproliferative effects related to p53 functional status of oral squamous cell carcinoma (OSCC) for its chemoadjuvant potential. Methods:  We used GSP to investigate SCC‐25 cells with wild‐type p53 gene and OEC‐M1 cells with mutant p53 gene for the assessment of antiproliferative effects including cell viability, cell cycle, apoptosis, migration and invasion potential, and alterations of associated oncoproteins involved in cellular and molecular events. Results:  The findings suggest that GSP on OEC‐M1 cells leads to cell cycle arrest by increasing the expression of p21Cip1/p27Kip1 protein without functioning mitochondria‐mediated apoptosis, whereas GSP on SCC‐25 cells inhibits cell proliferation via both G1‐phase arrest and mitochondria‐mediated apoptosis in a dose‐dependent manner as a result of alterations of Bcl‐2. GSP also inhibits the migration and invasion of both cells, which are associated with the suppression of matrix metalloproteinases (MMPs), MMP‐2 and MMP‐9. Conclusion:  Antiproliferative effectiveness of GSP is closely associated with the p53 status of OSCC cells. GSP displays chemoadjuvant potential via cell cycle blockage and apoptotic induction. Our findings clearly suggest that GSP may play a role as a novel chemopreventive or therapeutic agent for OSCC.</description><identifier>ISSN: 0904-2512</identifier><identifier>EISSN: 1600-0714</identifier><identifier>DOI: 10.1111/j.1600-0714.2011.01103.x</identifier><identifier>PMID: 22103929</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Anticarcinogenic Agents - pharmacology ; Antineoplastic Agents - pharmacology ; Apoptosis ; Apoptosis - drug effects ; Bcl-2 protein ; Biological and medical sciences ; Carcinoma, Squamous Cell - pathology ; Cell cycle ; Cell Cycle - drug effects ; Cell Death - drug effects ; Cell Line, Tumor ; Cell migration ; Cell Movement - drug effects ; Cell proliferation ; Cell Proliferation - drug effects ; Cell Survival - drug effects ; Cyclin-dependent kinase inhibitor p21 ; Cyclin-Dependent Kinase Inhibitor p21 - drug effects ; Cyclin-dependent kinase inhibitor p27 ; Cyclin-Dependent Kinase Inhibitor p27 - drug effects ; Dentistry ; Dose-Response Relationship, Drug ; G1 Phase - drug effects ; Gelatinase A ; Gelatinase B ; Grape Seed Extract - pharmacology ; grape seed procyanidins ; Humans ; Matrix metalloproteinase ; Matrix Metalloproteinase 2 - drug effects ; Matrix Metalloproteinase 9 - drug effects ; Medical sciences ; Mitochondria ; Mitochondria - drug effects ; Mouth Neoplasms - pathology ; Neoplasm Invasiveness ; Oncogene Proteins - drug effects ; oral squamous cell carcinoma ; Otorhinolaryngology. Stomatology ; p53 ; p53 protein ; Plant Preparations - pharmacology ; Point Mutation - genetics ; Proanthocyanidins - pharmacology ; Protein Kinase Inhibitors - analysis ; Proto-Oncogene Proteins c-bcl-2 - drug effects ; Tumor Suppressor Protein p53 - drug effects ; Tumor Suppressor Protein p53 - genetics ; Tumors ; Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology ; Vitaceae ; Vitis</subject><ispartof>Journal of oral pathology &amp; medicine, 2012-04, Vol.41 (4), p.322-331</ispartof><rights>2011 John Wiley &amp; Sons A/S</rights><rights>2015 INIST-CNRS</rights><rights>2011 John Wiley &amp; Sons A/S.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4693-8fcc232f4469f7fc4a0485374ff91e7c84b5e8d6ed87f26df17718250e3caaac3</citedby><cites>FETCH-LOGICAL-c4693-8fcc232f4469f7fc4a0485374ff91e7c84b5e8d6ed87f26df17718250e3caaac3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1600-0714.2011.01103.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1600-0714.2011.01103.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=25668563$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22103929$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lin, Yaoh-Shiang</creatorcontrib><creatorcontrib>Chen, Su-Feng</creatorcontrib><creatorcontrib>Liu, Chia-Lin</creatorcontrib><creatorcontrib>Nieh, Shin</creatorcontrib><title>The chemoadjuvant potential of grape seed procyanidins on p53-related cell death in oral cancer cells</title><title>Journal of oral pathology &amp; medicine</title><addtitle>J Oral Pathol Med</addtitle><description>J Oral Pathol Med (2012) 41: 322–331 Background:  To clarify the efficacy of grape seed procyanidin (GSP) on antiproliferative effects related to p53 functional status of oral squamous cell carcinoma (OSCC) for its chemoadjuvant potential. Methods:  We used GSP to investigate SCC‐25 cells with wild‐type p53 gene and OEC‐M1 cells with mutant p53 gene for the assessment of antiproliferative effects including cell viability, cell cycle, apoptosis, migration and invasion potential, and alterations of associated oncoproteins involved in cellular and molecular events. Results:  The findings suggest that GSP on OEC‐M1 cells leads to cell cycle arrest by increasing the expression of p21Cip1/p27Kip1 protein without functioning mitochondria‐mediated apoptosis, whereas GSP on SCC‐25 cells inhibits cell proliferation via both G1‐phase arrest and mitochondria‐mediated apoptosis in a dose‐dependent manner as a result of alterations of Bcl‐2. GSP also inhibits the migration and invasion of both cells, which are associated with the suppression of matrix metalloproteinases (MMPs), MMP‐2 and MMP‐9. Conclusion:  Antiproliferative effectiveness of GSP is closely associated with the p53 status of OSCC cells. GSP displays chemoadjuvant potential via cell cycle blockage and apoptotic induction. Our findings clearly suggest that GSP may play a role as a novel chemopreventive or therapeutic agent for OSCC.</description><subject>Anticarcinogenic Agents - pharmacology</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Bcl-2 protein</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Cell cycle</subject><subject>Cell Cycle - drug effects</subject><subject>Cell Death - drug effects</subject><subject>Cell Line, Tumor</subject><subject>Cell migration</subject><subject>Cell Movement - drug effects</subject><subject>Cell proliferation</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - drug effects</subject><subject>Cyclin-dependent kinase inhibitor p21</subject><subject>Cyclin-Dependent Kinase Inhibitor p21 - drug effects</subject><subject>Cyclin-dependent kinase inhibitor p27</subject><subject>Cyclin-Dependent Kinase Inhibitor p27 - drug effects</subject><subject>Dentistry</subject><subject>Dose-Response Relationship, Drug</subject><subject>G1 Phase - drug effects</subject><subject>Gelatinase A</subject><subject>Gelatinase B</subject><subject>Grape Seed Extract - pharmacology</subject><subject>grape seed procyanidins</subject><subject>Humans</subject><subject>Matrix metalloproteinase</subject><subject>Matrix Metalloproteinase 2 - drug effects</subject><subject>Matrix Metalloproteinase 9 - drug effects</subject><subject>Medical sciences</subject><subject>Mitochondria</subject><subject>Mitochondria - drug effects</subject><subject>Mouth Neoplasms - pathology</subject><subject>Neoplasm Invasiveness</subject><subject>Oncogene Proteins - drug effects</subject><subject>oral squamous cell carcinoma</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>p53</subject><subject>p53 protein</subject><subject>Plant Preparations - pharmacology</subject><subject>Point Mutation - genetics</subject><subject>Proanthocyanidins - pharmacology</subject><subject>Protein Kinase Inhibitors - analysis</subject><subject>Proto-Oncogene Proteins c-bcl-2 - drug effects</subject><subject>Tumor Suppressor Protein p53 - drug effects</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><subject>Tumors</subject><subject>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</subject><subject>Vitaceae</subject><subject>Vitis</subject><issn>0904-2512</issn><issn>1600-0714</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkV9v0zAUxS0EYt3GV0B-QfCS4P9OHnhAE4xNE4NRtEfLc66pS5pkdsrab4-zlvKGsGTZ1v0d-_hchDAlJc3j7bKkipCCaCpKRigt8yS83DxBs0PhKZqRmoiCScqO0HFKS0Ko5oI-R0eMZbxm9QzBfAHYLWDV22a5_mW7EQ_9CN0YbIt7j39EOwBOAA0eYu-2tgtN6BLuOzxIXkRo7ZhrDtoWN2DHBQ4d7mMWO9s5iI-VdIqeedsmeLFfT9D3jx_mZ5-Kq-vzi7P3V4UTquZF5Z1jnHmRT157JywRleRaeF9T0K4SdxKqRkFTac9U46nWtGKSAHfWWsdP0Ovdvdnr_RrSaFYhTQ5sB_06mfxlSbSoWSbf_JOkhDGpBBN1Rqsd6mKfUgRvhhhWNm4zZKZ2mKWZUjdT6mZqh3lsh9lk6cv9K-u7FTQH4Z_8M_BqD9jkbOtjDi2kv5xUqpKKZ-7djnsILWz_24C5vP4y7bK-2OlDGmFz0Nv40yjNtTS3n88NF2r-7Su5Mbf8N1iwtDo</recordid><startdate>201204</startdate><enddate>201204</enddate><creator>Lin, Yaoh-Shiang</creator><creator>Chen, Su-Feng</creator><creator>Liu, Chia-Lin</creator><creator>Nieh, Shin</creator><general>Blackwell Publishing Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>201204</creationdate><title>The chemoadjuvant potential of grape seed procyanidins on p53-related cell death in oral cancer cells</title><author>Lin, Yaoh-Shiang ; Chen, Su-Feng ; Liu, Chia-Lin ; Nieh, Shin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4693-8fcc232f4469f7fc4a0485374ff91e7c84b5e8d6ed87f26df17718250e3caaac3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Anticarcinogenic Agents - pharmacology</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Bcl-2 protein</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Cell cycle</topic><topic>Cell Cycle - drug effects</topic><topic>Cell Death - drug effects</topic><topic>Cell Line, Tumor</topic><topic>Cell migration</topic><topic>Cell Movement - drug effects</topic><topic>Cell proliferation</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - drug effects</topic><topic>Cyclin-dependent kinase inhibitor p21</topic><topic>Cyclin-Dependent Kinase Inhibitor p21 - drug effects</topic><topic>Cyclin-dependent kinase inhibitor p27</topic><topic>Cyclin-Dependent Kinase Inhibitor p27 - drug effects</topic><topic>Dentistry</topic><topic>Dose-Response Relationship, Drug</topic><topic>G1 Phase - drug effects</topic><topic>Gelatinase A</topic><topic>Gelatinase B</topic><topic>Grape Seed Extract - pharmacology</topic><topic>grape seed procyanidins</topic><topic>Humans</topic><topic>Matrix metalloproteinase</topic><topic>Matrix Metalloproteinase 2 - drug effects</topic><topic>Matrix Metalloproteinase 9 - drug effects</topic><topic>Medical sciences</topic><topic>Mitochondria</topic><topic>Mitochondria - drug effects</topic><topic>Mouth Neoplasms - pathology</topic><topic>Neoplasm Invasiveness</topic><topic>Oncogene Proteins - drug effects</topic><topic>oral squamous cell carcinoma</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>p53</topic><topic>p53 protein</topic><topic>Plant Preparations - pharmacology</topic><topic>Point Mutation - genetics</topic><topic>Proanthocyanidins - pharmacology</topic><topic>Protein Kinase Inhibitors - analysis</topic><topic>Proto-Oncogene Proteins c-bcl-2 - drug effects</topic><topic>Tumor Suppressor Protein p53 - drug effects</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><topic>Tumors</topic><topic>Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology</topic><topic>Vitaceae</topic><topic>Vitis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lin, Yaoh-Shiang</creatorcontrib><creatorcontrib>Chen, Su-Feng</creatorcontrib><creatorcontrib>Liu, Chia-Lin</creatorcontrib><creatorcontrib>Nieh, Shin</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of oral pathology &amp; medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lin, Yaoh-Shiang</au><au>Chen, Su-Feng</au><au>Liu, Chia-Lin</au><au>Nieh, Shin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The chemoadjuvant potential of grape seed procyanidins on p53-related cell death in oral cancer cells</atitle><jtitle>Journal of oral pathology &amp; medicine</jtitle><addtitle>J Oral Pathol Med</addtitle><date>2012-04</date><risdate>2012</risdate><volume>41</volume><issue>4</issue><spage>322</spage><epage>331</epage><pages>322-331</pages><issn>0904-2512</issn><eissn>1600-0714</eissn><abstract>J Oral Pathol Med (2012) 41: 322–331 Background:  To clarify the efficacy of grape seed procyanidin (GSP) on antiproliferative effects related to p53 functional status of oral squamous cell carcinoma (OSCC) for its chemoadjuvant potential. Methods:  We used GSP to investigate SCC‐25 cells with wild‐type p53 gene and OEC‐M1 cells with mutant p53 gene for the assessment of antiproliferative effects including cell viability, cell cycle, apoptosis, migration and invasion potential, and alterations of associated oncoproteins involved in cellular and molecular events. Results:  The findings suggest that GSP on OEC‐M1 cells leads to cell cycle arrest by increasing the expression of p21Cip1/p27Kip1 protein without functioning mitochondria‐mediated apoptosis, whereas GSP on SCC‐25 cells inhibits cell proliferation via both G1‐phase arrest and mitochondria‐mediated apoptosis in a dose‐dependent manner as a result of alterations of Bcl‐2. GSP also inhibits the migration and invasion of both cells, which are associated with the suppression of matrix metalloproteinases (MMPs), MMP‐2 and MMP‐9. Conclusion:  Antiproliferative effectiveness of GSP is closely associated with the p53 status of OSCC cells. GSP displays chemoadjuvant potential via cell cycle blockage and apoptotic induction. Our findings clearly suggest that GSP may play a role as a novel chemopreventive or therapeutic agent for OSCC.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>22103929</pmid><doi>10.1111/j.1600-0714.2011.01103.x</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0904-2512
ispartof Journal of oral pathology & medicine, 2012-04, Vol.41 (4), p.322-331
issn 0904-2512
1600-0714
language eng
recordid cdi_proquest_miscellaneous_929507492
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Anticarcinogenic Agents - pharmacology
Antineoplastic Agents - pharmacology
Apoptosis
Apoptosis - drug effects
Bcl-2 protein
Biological and medical sciences
Carcinoma, Squamous Cell - pathology
Cell cycle
Cell Cycle - drug effects
Cell Death - drug effects
Cell Line, Tumor
Cell migration
Cell Movement - drug effects
Cell proliferation
Cell Proliferation - drug effects
Cell Survival - drug effects
Cyclin-dependent kinase inhibitor p21
Cyclin-Dependent Kinase Inhibitor p21 - drug effects
Cyclin-dependent kinase inhibitor p27
Cyclin-Dependent Kinase Inhibitor p27 - drug effects
Dentistry
Dose-Response Relationship, Drug
G1 Phase - drug effects
Gelatinase A
Gelatinase B
Grape Seed Extract - pharmacology
grape seed procyanidins
Humans
Matrix metalloproteinase
Matrix Metalloproteinase 2 - drug effects
Matrix Metalloproteinase 9 - drug effects
Medical sciences
Mitochondria
Mitochondria - drug effects
Mouth Neoplasms - pathology
Neoplasm Invasiveness
Oncogene Proteins - drug effects
oral squamous cell carcinoma
Otorhinolaryngology. Stomatology
p53
p53 protein
Plant Preparations - pharmacology
Point Mutation - genetics
Proanthocyanidins - pharmacology
Protein Kinase Inhibitors - analysis
Proto-Oncogene Proteins c-bcl-2 - drug effects
Tumor Suppressor Protein p53 - drug effects
Tumor Suppressor Protein p53 - genetics
Tumors
Upper respiratory tract, upper alimentary tract, paranasal sinuses, salivary glands: diseases, semeiology
Vitaceae
Vitis
title The chemoadjuvant potential of grape seed procyanidins on p53-related cell death in oral cancer cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T04%3A06%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20chemoadjuvant%20potential%20of%20grape%20seed%20procyanidins%20on%20p53-related%20cell%20death%20in%20oral%20cancer%20cells&rft.jtitle=Journal%20of%20oral%20pathology%20&%20medicine&rft.au=Lin,%20Yaoh-Shiang&rft.date=2012-04&rft.volume=41&rft.issue=4&rft.spage=322&rft.epage=331&rft.pages=322-331&rft.issn=0904-2512&rft.eissn=1600-0714&rft_id=info:doi/10.1111/j.1600-0714.2011.01103.x&rft_dat=%3Cproquest_cross%3E1022564249%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1022564249&rft_id=info:pmid/22103929&rfr_iscdi=true